Brought to you by 
SeraCare acquires two Boston Biomedica divisions
05 May 2004
Executive Summary
In a cash transaction, SeraCare Life Sciences (diagnostic test component manufacturing, commercial drug production, and research products and services for therapeutic and diagnostic applications) will acquire almost all of the assets of BBI Diagnostics and BBI Biotech Research Labs, both divisions of Boston Biomedica.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SeraCare acquires two Boston Biomedica divisions
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice